In vivo data collected from early life studies may suggest that neuronal TLR3 stimulation is detrimental in neurodegenerative disease, especially in the context of viral infections including Epstein-Barr virus and hepatitis C [46]. This evidence concerns the gene TLR3 and neurodegenerative disease.